Ventyx Biosciences IncNASDAQ:VTYX
- LAST PRICE4.1900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.1900/ 1
- Ask / Lots4.3500/ 9
- Open / Previous Close0.0000 / 4.1900
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VTYX |
|---|---|---|
| 09:32 ET | 3499 | 4.32 |
| 09:34 ET | 1400 | 4.32 |
| 09:39 ET | 1000 | 4.2842 |
| 09:41 ET | 500 | 4.2963 |
| 09:43 ET | 2600 | 4.27 |
| 09:50 ET | 900 | 4.23 |
| 09:52 ET | 100 | 4.22 |
| 09:56 ET | 3368 | 4.17 |
| 09:57 ET | 1931 | 4.15 |
| 09:59 ET | 4270 | 4.11 |
| 10:01 ET | 300 | 4.13 |
| 10:03 ET | 3653 | 4.18 |
| 10:06 ET | 2960 | 4.21 |
| 10:08 ET | 4850 | 4.2012 |
| 10:10 ET | 1053 | 4.22 |
| 10:12 ET | 4133 | 4.21 |
| 10:14 ET | 1230 | 4.201 |
| 10:15 ET | 2268 | 4.215 |
| 10:17 ET | 100 | 4.215 |
| 10:19 ET | 750 | 4.22 |
| 10:21 ET | 400 | 4.24 |
| 10:26 ET | 100 | 4.25 |
| 10:28 ET | 100 | 4.24 |
| 10:30 ET | 1800 | 4.25 |
| 10:32 ET | 1606 | 4.26 |
| 10:33 ET | 649 | 4.28 |
| 10:35 ET | 700 | 4.28 |
| 10:37 ET | 3047 | 4.25 |
| 10:39 ET | 1200 | 4.24 |
| 10:42 ET | 1897 | 4.2322 |
| 10:44 ET | 100 | 4.22 |
| 10:46 ET | 1400 | 4.22 |
| 10:50 ET | 620 | 4.23 |
| 10:51 ET | 1035 | 4.23 |
| 10:55 ET | 2026 | 4.23 |
| 11:00 ET | 460 | 4.2203 |
| 11:02 ET | 1200 | 4.24 |
| 11:04 ET | 200 | 4.255 |
| 11:08 ET | 100 | 4.255 |
| 11:09 ET | 800 | 4.26 |
| 11:11 ET | 225 | 4.2699 |
| 11:13 ET | 200 | 4.265 |
| 11:15 ET | 300 | 4.27 |
| 11:18 ET | 1854 | 4.265 |
| 11:20 ET | 699 | 4.27 |
| 11:26 ET | 1300 | 4.295 |
| 11:29 ET | 3189 | 4.29 |
| 11:31 ET | 200 | 4.29 |
| 11:33 ET | 700 | 4.29 |
| 11:36 ET | 500 | 4.2911 |
| 11:40 ET | 616 | 4.2984 |
| 11:42 ET | 2000 | 4.2801 |
| 11:44 ET | 4497 | 4.29 |
| 11:45 ET | 1575 | 4.29 |
| 11:47 ET | 2190 | 4.29 |
| 11:54 ET | 1174 | 4.295 |
| 11:56 ET | 662 | 4.295 |
| 11:58 ET | 100 | 4.295 |
| 12:00 ET | 200 | 4.2975 |
| 12:02 ET | 1100 | 4.295 |
| 12:03 ET | 100 | 4.3 |
| 12:05 ET | 700 | 4.28 |
| 12:07 ET | 100 | 4.28 |
| 12:09 ET | 1898 | 4.27 |
| 12:12 ET | 100 | 4.27 |
| 12:16 ET | 200 | 4.27 |
| 12:18 ET | 100 | 4.27 |
| 12:21 ET | 100 | 4.26 |
| 12:23 ET | 100 | 4.26 |
| 12:27 ET | 735 | 4.26 |
| 12:30 ET | 2408 | 4.26 |
| 12:38 ET | 100 | 4.26 |
| 12:41 ET | 100 | 4.26 |
| 12:43 ET | 200 | 4.26 |
| 12:45 ET | 1309 | 4.275 |
| 12:50 ET | 1500 | 4.29 |
| 12:52 ET | 1332 | 4.2901 |
| 12:54 ET | 725 | 4.31 |
| 12:56 ET | 100 | 4.31 |
| 01:01 ET | 100 | 4.31 |
| 01:03 ET | 1868 | 4.3 |
| 01:06 ET | 700 | 4.295 |
| 01:08 ET | 100 | 4.29 |
| 01:12 ET | 906 | 4.27 |
| 01:17 ET | 3432 | 4.3 |
| 01:19 ET | 863 | 4.3 |
| 01:24 ET | 2726 | 4.29 |
| 01:26 ET | 1082 | 4.3 |
| 01:28 ET | 2600 | 4.305 |
| 01:30 ET | 216 | 4.305 |
| 01:32 ET | 600 | 4.3116 |
| 01:33 ET | 386 | 4.315 |
| 01:37 ET | 100 | 4.3175 |
| 01:39 ET | 3923 | 4.31 |
| 01:46 ET | 100 | 4.3 |
| 01:48 ET | 200 | 4.305 |
| 01:50 ET | 3548 | 4.285 |
| 01:55 ET | 700 | 4.28 |
| 01:57 ET | 100 | 4.27 |
| 02:00 ET | 3750 | 4.27 |
| 02:04 ET | 4052 | 4.2799 |
| 02:06 ET | 314 | 4.2813 |
| 02:08 ET | 100 | 4.285 |
| 02:09 ET | 3700 | 4.2801 |
| 02:11 ET | 400 | 4.28 |
| 02:13 ET | 1625 | 4.29 |
| 02:15 ET | 100 | 4.29 |
| 02:18 ET | 300 | 4.285 |
| 02:20 ET | 2031 | 4.3 |
| 02:22 ET | 200 | 4.3 |
| 02:24 ET | 100 | 4.31 |
| 02:27 ET | 200 | 4.305 |
| 02:29 ET | 200 | 4.3 |
| 02:31 ET | 100 | 4.3 |
| 02:33 ET | 300 | 4.305 |
| 02:36 ET | 3550 | 4.3 |
| 02:38 ET | 500 | 4.3 |
| 02:42 ET | 547 | 4.3 |
| 02:44 ET | 323 | 4.3 |
| 02:45 ET | 559 | 4.295 |
| 02:47 ET | 7282 | 4.295 |
| 02:49 ET | 471 | 4.29 |
| 02:51 ET | 5100 | 4.29 |
| 02:54 ET | 100 | 4.29 |
| 03:00 ET | 700 | 4.28 |
| 03:02 ET | 100 | 4.28 |
| 03:03 ET | 1709 | 4.29 |
| 03:05 ET | 876 | 4.28 |
| 03:07 ET | 100 | 4.275 |
| 03:09 ET | 4885 | 4.29 |
| 03:20 ET | 100 | 4.3 |
| 03:21 ET | 633 | 4.305 |
| 03:23 ET | 12329 | 4.305 |
| 03:25 ET | 755 | 4.3 |
| 03:30 ET | 9634 | 4.305 |
| 03:32 ET | 671 | 4.31 |
| 03:34 ET | 2725 | 4.295 |
| 03:36 ET | 1300 | 4.295 |
| 03:38 ET | 200 | 4.295 |
| 03:39 ET | 1926 | 4.275 |
| 03:41 ET | 1158 | 4.26 |
| 03:43 ET | 800 | 4.26 |
| 03:45 ET | 4447 | 4.24 |
| 03:50 ET | 3200 | 4.24 |
| 03:52 ET | 10430 | 4.245 |
| 03:54 ET | 1050 | 4.245 |
| 03:56 ET | 27060 | 4.22 |
| 03:57 ET | 6133 | 4.205 |
| 03:59 ET | 104830 | 4.19 |
May 14, 2024
NASDAQ INVESTIGATION NOTIFICATION Leading Law Firm BFA LLP Alerts VTYX Investors that Directors of Ventyx Biosciences Are Being Investigated for Potential Breaches of Fiduciary Duty, from 4:12PM ET on Tuesday May 14, 2024 by Dow Jones
4:12PM ET on Tuesday May 14, 2024 by Dow JonesVENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) SHAREHOLDER ALERT: The Directors of Ventyx Biosciences, Inc. Are Being Investigated for Potential Breaches of Fiduciary Duty by Leading Law Firm Bleichmar Fonti & Auld LLP; Contact the Firm for More Details, from 8:37AM ET on Tuesday May 14, 2024 by Dow Jones
8:37AM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
VTYX ALERT: Top Law Firm Bleichmar Fonti & Auld LLP Is Investigating the Directors of Ventyx Biosciences, Inc. for Potential Breaches of Fiduciary Duty; Contact the Firm for More Details, from 9:03PM ET on Monday May 13, 2024 by Dow Jones
9:03PM ET on Monday May 13, 2024 by Dow JonesVENTYX BIOSCIENCES, INC. INVESTIGATION ALERT (NASDAQ:VTYX): Top Law Firm Bleichmar Fonti & Auld LLP Notifies Investors that the Directors of Ventyx Biosciences, Inc. Are Being Investigated for Potential Breaches of Fiduciary Duty; Investors Are Encouraged to Contact the Firm, from 5:03AM ET on Monday May 13, 2024 by Dow Jones
5:03AM ET on Monday May 13, 2024 by Dow Jones
May 11, 2024
VENTYX BIOSCIENCES, INC. INVESTOR ALERT (NASDAQ: VTYX): The Directors of Ventyx Biosciences, Inc. Are Being Investigated for Potential Breaches of Fiduciary Duty; Top Law Firm Bleichmar Fonti & Auld LLP Encourages Investors to Contact the Firm, from 4:17AM ET on Saturday May 11, 2024 by Dow Jones
4:17AM ET on Saturday May 11, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ventyx Biosciences Inc | 295.4M | -1.3x | --- |
Opthea Ltd | 294.1M | -1.4x | --- |
Invivyd Inc | 293.3M | -1.3x | --- |
Actinium Pharmaceuticals Inc | 289.8M | -5.7x | --- |
Inozyme Pharma Inc | 288.9M | -3.4x | --- |
Black Diamond Therapeutics Inc | 306.0M | -3.2x | --- |
Company Information
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a pipeline of small molecule product candidates to address a range of inflammatory diseases with unmet need. The Company’s pipeline includes VTX002 (S1P1R Modulator), VTX958 (TYK2 Inhibitor), and VTX2735 and VTX3232 (NLRP3 Inhibitor Portfolio). VTX002 is a sphingosine 1 phosphate receptor (S1P1R) modulator in Phase II development for patients with moderately to severely active ulcerative colitis (UC). VTX958 is an oral, selective clinical-stage inhibitor of tyrosine kinase type 2 (TYK2), an intracellular signaling kinase in the Janus kinase (JAK) family that regulates chronic inflammation in immune-mediated diseases. Its third product candidate, VTX2735, is a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor. In addition to VTX2735, it is also developing VTX3232, its lead CNS-penetrant NLRP3 inhibitor in Phase 1 development.
Contact Information
- Headquarters
- 12790 El Camino Real, Suite 200SAN DIEGO, CA, United States 92130
- Phone
- 858-945-2393
- Fax
- 302-655-5049
Executives
- Executive Chairperson of the Board
- Sheila Gujrathi
- President, Chief Executive Officer, Founder, Director
- Raju Mohan
- Chief Financial Officer
- Martin Auster
- Chief Scientific Officer
- John Nuss
- Independent Director
- Onaiza Cadoret-manier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $295.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-3.24 |
Book Value | $4.12 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
